IP Library Granted Patent US 7,910,346
Granted Patent B2
US 7,910,346 · App. 12/378,703 · Granted Mar 22, 2011

Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor

Assignee: Millennium Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,346
App. No.
12/378,703
Granted
Mar 22, 2011
Kind
B2
Abstract

The present invention relates to compositions and methods for the diagnosis and treatment of obesity and related metabolic disorders. The invention provides isolated nucleic acids molecules, designated DGAT2 family member nucleic acid molecules, which encode diacylglycerol acyltransferase family members. The invention also provides recombinant expression vectors containing DGAT2 family member nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DGAT2 family member gene has been introduced or disrupted. The invention still further provides isolated DGAT2 family member proteins, fusion proteins, antigenic peptides and anti-DGAT2 family member antibodies. Methods of use of the provided DGAT2 family member compositions for screening, diagnostic and therapeutic methods in connection with obesity disorders are also disclosed.

Claims (2)

1. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:8.

2. An isolated polypeptide which is encoded by a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:7.

Continuity (5)
Division 11296615 · Dec 7, 2005
Division 10324618 · Dec 19, 2002
Provisional Application 60341947 · Dec 19, 2001
Provisional Application 60411859 · Sep 19, 2002
Related Publication 20090269332A1 · Oct 29, 2009